Bayesian Statistics Approach Offers Benefits To Sponsors, FDA Staffers Say
This article was originally published in The Gray Sheet
Executive Summary
Use of Bayesian statistics in designing Guidant's Multi-Link Duet stent trial would have halved the number of enrollees required for FDA approval, according to Guidant Senior Biostatistician Frank Hu.